GlassScriptPhysician profile
Kuldip J Behniwal
NPI 1356346365
$7,529.48
in general payments reported to CMS, 2019-2025
37 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,052 · 2020: $178 · 2021: $355 · 2022: $603 · 2023: $1,429 · 2024: $2,132 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,688 · Travel and Lodging: $1,084 · Education: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,688.13 |
| Travel and Lodging | $1,084.16 |
| Education | $570.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,906.84 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $1,012.36 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $901.02 | 2019-2025 | Padcev, Xtandi |
| Boston Scientific Corporation | $519.58 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Coloplast Corp | $385.45 | 2019-2024 | Altis, Speedicath |
| Pfizer INC. | $256.66 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $234.82 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $224.81 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $192.03 | 2021-2023 | Xiaflex |
| Ferring Pharmaceuticals INC. | $145.12 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $133.05 | 2019-2025 | |
| Olympus America INC. | $117.12 | 2022-2024 | Itind System |
| Astrazeneca Pharmaceuticals LP | $111.97 | 2022-2025 | Lynparza, Imfinzi |
| Novartis Pharmaceuticals Corporation | $111.78 | 2024-2025 | |
| Myovant Sciences INC. | $105.28 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $103.47 | 2023 | |
| Neotract INC. | $102.71 | 2019 | |
| Allergan, INC. | $101.26 | 2019-2020 | |
| Antares Pharma, INC. | $86.35 | 2022-2025 | Xyosted |
| Caris Mpi, INC. | $77.71 | 2025 | Mi Cancer Seek |
| Progenics Pharmaceuticals, INC. | $74.93 | 2022-2025 | |
| Medtronic USA, INC. | $69.50 | 2019 | |
| Accord Healthcare, INC. | $67.03 | 2022-2024 | |
| Urovant Sciences INC | $61.36 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $57.51 | 2020-2022 | |
| Abbvie INC. | $55.26 | 2024-2025 | |
| Tempus Ai, INC | $52.86 | 2024-2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $44.00 | 2022 | |
| Endo USA, INC. | $43.29 | 2025 | Xiaflex, Aveed |
| Amgen INC. | $30.91 | 2022 | |
| Laborie Medical Technologies Corp. | $30.15 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Profound Medical Corp. | $27.06 | 2025 | Tulsa-Pro |
| Urogen Pharma, INC. | $23.67 | 2024 | |
| Immunitybio, INC. | $19.55 | 2024 | |
| Procept Biorobotics Corporation | $18.35 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.63 | 2019 | |
| Blue Earth Diagnostics | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kuldip Behniwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.